AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PTC THERAPEUTICS, INC. Director's Dealing 2021

Jan 27, 2021

31046_dirs_2021-01-27_8eb38d2a-a53d-455e-8a1a-e7a70d7702e2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2021-01-25

Reporting Person: Almstead Neil Gregory (Chief Technical Ops Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-25	Common Stock	S	497	$63.25	Disposed	1891	Indirect
2021-01-25	Common Stock	S	44	$62.054	Disposed	1847	Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the spouse of the Reporting Person on November 10, 2020.

F2: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 143 RSUs from a January 22, 2019 grant of 570 RSUs.